Strategic Global Advisors, LLC Gilead Sciences, Inc. Transaction History

Strategic Global Advisors, LLC

$459 Million
Q1 2024

A detailed history of Strategic Global Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 35,461 shares of GILD stock, worth $2.36 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

35,461

Previous 36,510 2.87%

Holding current value

$2.36 Million

Previous $2.96 Million 12.17%

% of portfolio

0.57%

Previous 0.68%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $75,087 - $91,567	-1,049 Reduced 2.87%	35,461 $2.6 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.86 Million - $2.11 Million	-25,408 Reduced 41.03%	36,510 $2.96 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $225,664 - $246,204	-3,052 Reduced 4.7%	61,918 $4.64 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $4.94 Million - $5.63 Million	64,970 New	64,970 $5.01 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $2.37 Million - $2.7 Million	-41,868 Closed	0 $0

Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $230,328 - $289,598	3,709 Added 9.72%	41,868 $2.65 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $529,022 - $614,292	-7,313 Reduced 16.08%	38,159 $2.94 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $125,698 - $161,001	-2,007 Reduced 4.23%	45,472 $3.4 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $168,345 - $185,174	-2,732 Reduced 5.44%	47,479 $3.09 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $268,292 - $296,148	-4,292 Reduced 7.87%	50,211 $3.18 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $199,963 - $224,236	-3,232 Reduced 5.6%	54,503 $3.68 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $1.41 Million - $1.58 Million	22,625 Added 64.44%	57,735 $3.75 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $289,986 - $378,410	-4,790 Reduced 12.01%	35,110 $2.2 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $9,052 - $10,022	-127 Reduced 0.32%	39,900 $3.08 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $93,206 - $109,411	-1,310 Reduced 3.17%	40,027 $2.87 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.98 Million - $3.53 Million	41,337	41,337 $3.35 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.

Account

Strategic Global Advisors, LLC Gilead Sciences, Inc. Transaction History